Extendicare Inc. (OTCMKTS:EXETF – Get Free Report)’s share price fell 0.9% on Wednesday. The company traded as low as $19.53 and last traded at $19.53. Approximately 14,783 shares traded hands during mid-day trading, a decline of 78% from the average session volume of 68,108 shares. The stock had previously closed at $19.7150.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on the stock. Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of Extendicare in a report on Monday. Royal Bank Of Canada reissued an “outperform” rating on shares of Extendicare in a research note on Friday, August 14th. Five equities research analysts have rated the stock with a Buy rating. Based on data from MarketBeat.com, the company currently has an average rating of “Buy”.
Read Our Latest Research Report on Extendicare
Extendicare Trading Up 0.6%
The company has a fifty day moving average of $20.91 and a two-hundred day moving average of $21.52.
About Extendicare
Extendicare Inc is a Canadian provider of healthcare and support services for seniors. The company operates long-term care homes and retirement communities, serving residents who require assisted living, complex care, rehabilitation, and other continuing-care services.
Extendicare also provides home healthcare through its ParaMed business. These services include nursing, personal support, rehabilitation, and other care delivered in patients’ homes, helping individuals maintain independence and supporting families and caregivers.
The company’s operations are primarily focused on Canada, with a presence in several provinces, including Ontario and Western Canada.
Recommended Stories
- Five stocks we like better than Extendicare
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
